Stay updated on ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM
Sign up to get notified when there's something new on the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page.

Latest updates to the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page
- Check4 days agoChange DetectedThe page revision now shows v3.0.2, replacing v3.0.1, indicating an updated version. The 'Back to Top' link was removed, with no changes to pricing, stock, or time slot information.SummaryDifference0.1%
- Check11 days agoChange DetectedThe web page has been updated to include information on Multiple myeloma under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference0.3%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location in Prague, Czechia, as well as new medical terms related to plasma cell myeloma and various chemical compounds. Notably, several previous terms and references related to multiple myeloma and specific drugs have been removed.SummaryDifference4%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
Stay in the know with updates to ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM
Enter your email address, and we'll notify you when there's something new on the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page.